| 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane | increases expression | ISO | RGD:619568 | 6480464 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased expression of CAV1 protein | CTD | PMID:19706615 |
| 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane | multiple interactions | ISO | RGD:619568 | 6480464 | 2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased ubiquitination of and results in decreased degradation of CAV1 protein; more ... | CTD | PMID:19706615 |
| 17beta-estradiol | multiple interactions | ISO | RGD:619568 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV1 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases phosphorylation | ISO | RGD:619568 | 6480464 | Estradiol results in increased phosphorylation of CAV1 protein | CTD | PMID:18296501 |
| 17beta-estradiol | decreases expression | ISO | RGD:619568 | 6480464 | Estradiol results in decreased expression of CAV1 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:619568 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CAV1 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CAV1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:619568 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CAV1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:619568 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CAV1 mRNA | CTD | PMID:20106945 PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:619568 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CAV1 mRNA | CTD | PMID:19619570 PMID:20106945 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:1553438 | 6480464 | CAV1 affects the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:19265715 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:1553438 | 6480464 | CAV1 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VCAM1 protein]; more ... | CTD | PMID:20406653 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1553438 | 6480464 | CAV1 mutant form inhibits the reaction [3,4,3',4'-tetrachlorobiphenyl results in increased expression of VCAM1 protein]; more ... | CTD | PMID:20406653 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1553438 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl promotes the reaction [CAV1 protein binds to AHR protein]; more ... | CTD | PMID:18786521 |
| 3,3',4,4'-tetrachlorobiphenyl | increases expression | ISO | RGD:1553438 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl results in increased expression of CAV1 protein | CTD | PMID:18786521 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1553438 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA | CTD | PMID:16054899 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:619568 | 6480464 | [decitabine co-treated with Depsipeptides] results in decreased expression of CAV1 mRNA | CTD | PMID:17064661 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:619568 | 6480464 | decitabine results in increased expression of CAV1 mRNA | CTD | PMID:16367923 |
| 5-fluorouracil | affects response to substance | ISO | RGD:619568 | 6480464 | CAV1 protein affects the susceptibility to Fluorouracil | CTD | PMID:15352031 |
| 5-fluorouracil | decreases expression | ISO | RGD:619568 | 6480464 | Fluorouracil results in decreased expression of CAV1 protein | CTD | PMID:15352031 |
| acetylcholine | multiple interactions | ISO | RGD:1553438 | 6480464 | Sodium, Dietary affects the reaction [CAV1 protein affects the susceptibility to Acetylcholine] | CTD | PMID:18178722 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of CAV1 mRNA | CTD | PMID:12800193 |
| actinomycin D | multiple interactions | ISO | RGD:619568 | 6480464 | Dactinomycin inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] | CTD | PMID:15314095 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:619568 | 6480464 | Tretinoin results in decreased expression of CAV1 mRNA | CTD | PMID:21934132 |
| aminoguanidine | decreases expression | ISO | RGD:619568 | 6480464 | pimagedine results in decreased expression of CAV1 protein | CTD | PMID:19706615 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CAV1 mRNA | CTD | PMID:16483693 |
| ammonium chloride | decreases expression | EXP | | 6480464 | Ammonium Chloride results in decreased expression of CAV1 protein | CTD | PMID:16483693 |
| arsenite(3-) | multiple interactions | ISO | RGD:619568 | 6480464 | CAV1 protein inhibits the reaction [arsenite results in increased phosphorylation of MAPK1 protein]; more ... | CTD | PMID:12640124 |
| arsenite(3-) | multiple interactions | ISO | RGD:1553438 | 6480464 | tyrphostin 25 inhibits the reaction [arsenite results in increased phosphorylation of CAV1 protein] | CTD | PMID:14511371 |
| arsenite(3-) | increases phosphorylation | ISO | RGD:1553438 | 6480464 | arsenite results in increased phosphorylation of CAV1 protein | CTD | PMID:14511371 |
| benzo[a]pyrene | decreases expression | ISO | RGD:619568 | 6480464 | Benzo(a)pyrene results in decreased expression of CAV1 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:1553438 | 6480464 | Benzo(a)pyrene results in increased expression of CAV1 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1553438 | 6480464 | Benzo(a)pyrene results in decreased expression of CAV1 mRNA | CTD | PMID:19770486 |
| butyric acid | decreases expression | EXP | | 6480464 | Butyric Acid results in decreased expression of CAV1 mRNA | CTD | PMID:12800193 |
| cadmium atom | multiple interactions | ISO | RGD:1553438 | 6480464 | Cadmium promotes the reaction [HMOX1 protein binds to CAV1 protein] | CTD | PMID:14658758 |
| calcium atom | affects transport | ISO | RGD:1553438 | 6480464 | CAV1 protein affects the transport of Calcium | CTD | PMID:16428350 |
| calcium(0) | affects transport | ISO | RGD:1553438 | 6480464 | CAV1 protein affects the transport of Calcium | CTD | PMID:16428350 |
| caprylic acid | multiple interactions | ISO | RGD:1553438 | 6480464 | [caprylic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein; more ... | CTD | PMID:14984747 |
| celecoxib | increases expression | ISO | RGD:619568 | 6480464 | celecoxib results in increased expression of CAV1 protein | CTD | PMID:18848576 |
| cholesterol | increases transport | ISO | RGD:619568 | 6480464 | CAV1 protein results in increased transport of Cholesterol | CTD | PMID:12640124 |
| chromium atom | multiple interactions | EXP | | 6480464 | [Niacin co-treated with Chromium] results in decreased expression of CAV1 protein; more ... | CTD | PMID:19027847 |
| cisplatin | affects response to substance | ISO | RGD:619568 | 6480464 | CAV1 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CAV1 mRNA | CTD | PMID:22023808 |
| cisplatin | affects expression | ISO | RGD:1553438 | 6480464 | Cisplatin affects the expression of CAV1 mRNA | CTD | PMID:21151649 |
| clofibrate | affects expression | ISO | RGD:619568 | 6480464 | Clofibrate affects the expression of CAV1 protein | CTD | PMID:17961437 |
| cobalt dichloride | decreases expression | ISO | RGD:619568 | 6480464 | cobaltous chloride results in decreased expression of CAV1 mRNA | CTD | PMID:19320972 |
| coumestrol | multiple interactions | ISO | RGD:619568 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA | CTD | PMID:19167446 |
| coumestrol | increases expression | ISO | RGD:619568 | 6480464 | Coumestrol results in increased expression of CAV1 mRNA | CTD | PMID:19167446 |
| cumene | decreases expression | ISO | RGD:1553438 | 6480464 | cumene results in decreased expression of CAV1 mRNA | CTD | PMID:18648096 |
| cycloheximide | multiple interactions | ISO | RGD:619568 | 6480464 | Cycloheximide inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] | CTD | PMID:15314095 |
| cyclosporin A | decreases expression | ISO | RGD:619568 | 6480464 | Cyclosporine results in decreased expression of CAV1 mRNA | CTD | PMID:20106945 |
| D-glucose | multiple interactions | ISO | RGD:619568 | 6480464 | EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; more ... | CTD | PMID:19816600 |
| D-glucose | decreases expression | ISO | RGD:619568 | 6480464 | Glucose results in decreased expression of CAV1 mRNA; more ... | CTD | PMID:19816600 |
| desferrioxamine B | increases expression | ISO | RGD:619568 | 6480464 | Deferoxamine results in increased expression of CAV1 protein | CTD | PMID:16927372 |
| dexamethasone | multiple interactions | ISO | RGD:1553438 | 6480464 | [caprylic acid co-treated with Dexamethasone] results in increased expression of CAV1 protein; more ... | CTD | PMID:14984747 |
| dexamethasone | multiple interactions | ISO | RGD:1553438 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA | CTD | PMID:16054899 |
| diarsenic trioxide | increases expression | ISO | RGD:619568 | 6480464 | arsenic trioxide results in increased expression of CAV1 protein | CTD | PMID:17512576 |
| diarsenic trioxide | increases expression | ISO | RGD:619568 | 6480464 | arsenic trioxide results in increased expression of CAV1 mRNA | CTD | PMID:22521957 |
| diarsenic trioxide | decreases expression | ISO | RGD:619568 | 6480464 | arsenic trioxide results in decreased expression of CAV1 mRNA | CTD | PMID:15725085 |
| diazoxide | multiple interactions | ISO | RGD:1553438 | 6480464 | CAV1 protein promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] | CTD | PMID:18820136 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CAV1 mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of CAV1 mRNA | CTD | PMID:21658437 |
| dioxygen | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [[SU 5416 co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein]; more ... | CTD | PMID:16698853 |
| diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of CAV1 mRNA | CTD | PMID:21551480 |
| doxorubicin | affects response to substance | ISO | RGD:619568 | 6480464 | CAV1 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 |
| doxorubicin | increases expression | ISO | RGD:1553438 | 6480464 | Doxorubicin results in increased expression of CAV1 mRNA | CTD | PMID:22008532 |
| ethanol | increases expression | ISO | RGD:619568 | 6480464 | Ethanol results in increased expression of CAV1 mRNA | CTD | PMID:15963989 |
| fenofibrate | increases expression | ISO | RGD:619568 | 6480464 | Fenofibrate results in increased expression of CAV1 mRNA | CTD | PMID:15314095 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [Raloxifene results in increased expression of CAV1 protein]; more ... | CTD | PMID:17091190 |
| gefitinib | increases expression | ISO | RGD:619568 | 6480464 | gefitinib results in increased expression of CAV1 mRNA; more ... | CTD | PMID:19288272 |
| geranylgeraniol | multiple interactions | ISO | RGD:619568 | 6480464 | geranylgeraniol inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA] | CTD | PMID:15314095 |
| glucose | multiple interactions | ISO | RGD:619568 | 6480464 | EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; more ... | CTD | PMID:19816600 |
| glucose | decreases expression | ISO | RGD:619568 | 6480464 | Glucose results in decreased expression of CAV1 mRNA; more ... | CTD | PMID:19816600 |
| hydrogen peroxide | multiple interactions | ISO | RGD:619568 | 6480464 | Hydrogen Peroxide inhibits the reaction [Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein] | CTD | PMID:21148404 |
| hydrogen peroxide | multiple interactions | ISO | RGD:619568 | 6480464 | wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to Hydrogen Peroxide] | CTD | PMID:12640124 |
| hydrogen peroxide | increases response to substance | ISO | RGD:619568 | 6480464 | CAV1 protein results in increased susceptibility to Hydrogen Peroxide | CTD | PMID:12640124 |
| hydrogen peroxide | multiple interactions | ISO | RGD:619568 | 6480464 | Hydrogen Peroxide promotes the reaction [PTRF protein binds to CAV1 protein] | CTD | PMID:21705337 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1553438 | 6480464 | Hydrogen Peroxide promotes the reaction [MDM1 protein binds to CAV1 protein]; more ... | CTD | PMID:21705337 |
| hydrogen peroxide | increases expression | ISO | RGD:1553438 | 6480464 | Hydrogen Peroxide results in increased expression of CAV1 protein | CTD | PMID:12134086 PMID:17108117 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1553438 | 6480464 | Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] | CTD | PMID:12134086 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1553438 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] | CTD | PMID:12134086 PMID:17108117 |
| hydrogen peroxide | increases expression | ISO | RGD:1553438 | 6480464 | Hydrogen Peroxide results in increased expression of CAV1 protein | CTD | PMID:17108117 PMID:12134086 |
| hydrogen peroxide | increases expression | ISO | RGD:1553438 | 6480464 | Hydrogen Peroxide results in increased expression of CAV1 mRNA | CTD | PMID:12134086 |
| hydrogen peroxide | multiple interactions | ISO | RGD:619568 | 6480464 | SB 203580 inhibits the reaction [Hydrogen Peroxide promotes the reaction [SP1 protein results in increased expression of CAV1 protein]] | CTD | PMID:17108117 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1553438 | 6480464 | Hydrogen Peroxide promotes the reaction [SP1 protein binds to CAV1 promoter]; more ... | CTD | PMID:17108117 |
| hydrogen peroxide | multiple interactions | ISO | RGD:619568 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 mRNA]; more ... | CTD | PMID:18385095 |
| hydrogen peroxide | increases expression | ISO | RGD:619568 | 6480464 | Hydrogen Peroxide results in increased expression of CAV1 mRNA; more ... | CTD | PMID:18385095 |
| iron atom | affects localization | EXP | | 6480464 | Iron affects the localization of CAV1 protein | CTD | PMID:17172471 |
| isoprenaline | multiple interactions | ISO | RGD:1553438 | 6480464 | CAV1 protein promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] | CTD | PMID:18820136 |
| lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of CAV1 mRNA | CTD | PMID:11578147 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of CAV1 mRNA | CTD | PMID:22641619 |
| mifepristone | multiple interactions | ISO | RGD:619568 | 6480464 | Mifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA] | CTD | PMID:15674352 |
| N-acetyl-L-cysteine | decreases expression | ISO | RGD:619568 | 6480464 | Acetylcysteine results in decreased expression of CAV1 | CTD | PMID:21148404 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:619568 | 6480464 | Acetylcysteine inhibits the reaction [rosiglitazone results in increased expression of CAV1] | CTD | PMID:18507034 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:619568 | 6480464 | Acetylcysteine results in increased ubiquitination of and results in increased degradation of CAV1 protein; more ... | CTD | PMID:21148404 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:619568 | 6480464 | Diethylnitrosamine results in increased expression of CAV1 mRNA | CTD | PMID:21527772 |
| N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | Dimethylnitrosamine promotes the reaction [CAV1 protein binds to NOS3 protein] | CTD | PMID:18364076 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of CAV1 protein | CTD | PMID:18364076 |
| nicotinic acid | multiple interactions | EXP | | 6480464 | [Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein]; more ... | CTD | PMID:19027847 |
| nimesulide | increases expression | ISO | RGD:619568 | 6480464 | nimesulide results in increased expression of CAV1 protein | CTD | PMID:18848576 |
| nitric oxide | multiple interactions | ISO | RGD:619568 | 6480464 | Nitric Oxide results in decreased ubiquitination of and results in decreased degradation of CAV1 protein; more ... | CTD | PMID:19706615 |
| nitric oxide | multiple interactions | ISO | RGD:619568 | 6480464 | [resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]] which results in increased abundance of Nitric Oxide | CTD | PMID:18296501 |
| nitric oxide | increases expression | ISO | RGD:619568 | 6480464 | Nitric Oxide results in increased expression of CAV1 protein | CTD | PMID:19706615 |
| nitroprusside | multiple interactions | ISO | RGD:619568 | 6480464 | Nitroprusside results in decreased ubiquitination of and results in decreased degradation of CAV1 protein; more ... | CTD | PMID:19706615 |
| nitroprusside | increases expression | ISO | RGD:619568 | 6480464 | Nitroprusside results in increased expression of CAV1 protein | CTD | PMID:19706615 |
| ozone | decreases expression | ISO | RGD:1553438 | 6480464 | Ozone results in decreased expression of CAV1 protein | CTD | PMID:18207479 |
| ozone | multiple interactions | ISO | RGD:1553438 | 6480464 | TNF protein affects the reaction [Ozone results in decreased expression of CAV1 protein] | CTD | PMID:18207479 |
| ozone | decreases expression | ISO | RGD:1553438 | 6480464 | Ozone results in decreased expression of CAV1 mRNA | CTD | PMID:12763052 |
| paclitaxel | increases response to substance | ISO | RGD:619568 | 6480464 | CAV1 mRNA results in increased susceptibility to Paclitaxel | CTD | PMID:16322897 |
| paracetamol | decreases expression | ISO | RGD:1553438 | 6480464 | Acetaminophen results in decreased expression of CAV1 protein | CTD | PMID:20100502 |
| paracetamol | increases response to substance | ISO | RGD:1553438 | 6480464 | CAV1 results in increased susceptibility to Acetaminophen | CTD | PMID:20100502 |
| paracetamol | decreases expression | ISO | RGD:619568 | 6480464 | Acetaminophen results in decreased expression of CAV1 mRNA | CTD | PMID:21420995 |
| paracetamol | multiple interactions | ISO | RGD:1553438 | 6480464 | CAV1 affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:20100502 |
| phenylephrine | multiple interactions | ISO | RGD:1553438 | 6480464 | Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Phenylephrine] | CTD | PMID:18178722 |
| pioglitazone | affects expression | ISO | RGD:619568 | 6480464 | pioglitazone affects the expression of CAV1 protein | CTD | PMID:17961437 |
| pirinixic acid | multiple interactions | ISO | RGD:1553438 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CAV1 mRNA | CTD | PMID:19710929 |
| pirinixic acid | multiple interactions | ISO | RGD:619568 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CAV1 mRNA | CTD | PMID:19710929 |
| piroxicam | decreases expression | ISO | RGD:619568 | 6480464 | Piroxicam results in decreased expression of CAV1 mRNA | CTD | PMID:21858171 |
| potassium chloride | multiple interactions | ISO | RGD:1553438 | 6480464 | Sodium, Dietary affects the reaction [CAV1 protein results in increased susceptibility to Potassium Chloride] | CTD | PMID:18178722 |
| progesterone | increases expression | ISO | RGD:619568 | 6480464 | Progesterone results in increased expression of CAV1 mRNA | CTD | PMID:15674352 |
| progesterone | multiple interactions | ISO | RGD:619568 | 6480464 | Mifepristone inhibits the reaction [Progesterone results in increased expression of CAV1 mRNA] | CTD | PMID:15674352 |
| quercetin | multiple interactions | ISO | RGD:619568 | 6480464 | Nystatin inhibits the reaction [Quercetin affects the localization of CAV1 protein] | CTD | PMID:17876056 |
| quercetin | multiple interactions | ISO | RGD:1553438 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] | CTD | PMID:12134086 PMID:17108117 |
| quercetin | decreases expression | ISO | RGD:1553438 | 6480464 | Quercetin results in decreased expression of CAV1 protein | CTD | PMID:12134086 |
| quercetin | multiple interactions | ISO | RGD:1553438 | 6480464 | Quercetin inhibits the reaction [Quercetin results in increased expression of CAV1 mRNA] | CTD | PMID:12134086 |
| quercetin | multiple interactions | ISO | RGD:1553438 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] | CTD | PMID:17108117 PMID:12134086 |
| quercetin | multiple interactions | ISO | RGD:619568 | 6480464 | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 mRNA]; more ... | CTD | PMID:18385095 |
| raloxifene | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [Raloxifene results in increased expression of CAV1 mRNA]; more ... | CTD | PMID:17091190 |
| raloxifene | increases expression | EXP | | 6480464 | Raloxifene results in increased expression of CAV1 mRNA; more ... | CTD | PMID:17091190 |
| raloxifene | affects expression | ISO | RGD:619568 | 6480464 | Raloxifene affects the expression of CAV1 mRNA | CTD | PMID:14699072 |
| resveratrol | affects transport | ISO | RGD:619568 | 6480464 | CAV1 protein affects the transport of resveratrol | CTD | PMID:19321006 |
| resveratrol | multiple interactions | ISO | RGD:619568 | 6480464 | resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]; more ... | CTD | PMID:18296501 |
| resveratrol | multiple interactions | ISO | RGD:619568 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA | CTD | PMID:19167446 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CAV1 protein | CTD | PMID:18266981 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Streptozocin results in increased expression of CAV1 protein]; more ... | CTD | PMID:18266981 |
| resveratrol | increases phosphorylation | ISO | RGD:619568 | 6480464 | resveratrol results in increased phosphorylation of CAV1 protein | CTD | PMID:18296501 |
| resveratrol | increases response to substance | ISO | RGD:619568 | 6480464 | CAV1 protein results in increased susceptibility to resveratrol | CTD | PMID:19321006 |
| resveratrol | increases expression | ISO | RGD:619568 | 6480464 | resveratrol results in increased expression of CAV1 protein | CTD | PMID:19321006 |
| rosiglitazone | multiple interactions | ISO | RGD:619568 | 6480464 | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased expression of CAV1 protein] | CTD | PMID:16806087 |
| rosiglitazone | increases expression | ISO | RGD:619568 | 6480464 | rosiglitazone results in increased expression of CAV1 protein | CTD | PMID:16386711 more ... |
| rosiglitazone | increases expression | ISO | RGD:619568 | 6480464 | rosiglitazone results in increased expression of CAV1 protein | CTD | PMID:15314095 more ... |
| rosiglitazone | increases expression | ISO | RGD:619568 | 6480464 | rosiglitazone results in increased expression of CAV1 mRNA | CTD | PMID:16386711 PMID:15314095 |
| rosiglitazone | increases expression | ISO | RGD:619568 | 6480464 | rosiglitazone results in increased expression of CAV1 protein | CTD | PMID:16806087 more ... |
| rosiglitazone | increases expression | ISO | RGD:619568 | 6480464 | rosiglitazone results in increased expression of CAV1 protein | CTD | PMID:16386711 more ... |
| rosiglitazone | increases expression | ISO | RGD:619568 | 6480464 | rosiglitazone results in increased expression of CAV1 mRNA | CTD | PMID:15314095 PMID:16386711 |
| rosiglitazone | multiple interactions | ISO | RGD:619568 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of CAV1 mRNA]; more ... | CTD | PMID:15314095 |
| rosiglitazone | increases expression | ISO | RGD:1553438 | 6480464 | rosiglitazone results in increased expression of CAV1 mRNA | CTD | PMID:17245590 |
| rosiglitazone | increases expression | ISO | RGD:619568 | 6480464 | rosiglitazone results in increased expression of CAV1 | CTD | PMID:18507034 |
| rosiglitazone | multiple interactions | ISO | RGD:619568 | 6480464 | Acetylcysteine inhibits the reaction [rosiglitazone results in increased expression of CAV1]; more ... | CTD | PMID:18507034 |
| rosiglitazone | multiple interactions | ISO | RGD:1553438 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CAV1 mRNA | CTD | PMID:16054899 |
| rosiglitazone | increases expression | ISO | RGD:619568 | 6480464 | rosiglitazone results in increased expression of CAV1 protein | CTD | PMID:16806087 |
| simvastatin | multiple interactions | ISO | RGD:619568 | 6480464 | Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA] | CTD | PMID:19816600 |
| simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin inhibits the reaction [[SU 5416 co-treated with Oxygen deficiency] results in decreased expression of CAV1 protein]; more ... | CTD | PMID:16698853 |
| simvastatin | decreases expression | ISO | RGD:1553438 | 6480464 | Simvastatin results in decreased expression of CAV1 protein | CTD | PMID:18224302 |
| simvastatin | multiple interactions | ISO | RGD:1553438 | 6480464 | Simvastatin promotes the reaction [[APOA4 protein co-treated with CBS protein] affects the expression of CAV1 protein] | CTD | PMID:18224302 |
| streptozocin | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Streptozocin promotes the reaction [CAV1 protein binds to NOS3 protein]]; more ... | CTD | PMID:18266981 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of CAV1 protein | CTD | PMID:18266981 |
| sulfasalazine | multiple interactions | ISO | RGD:1553438 | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA] | CTD | PMID:19015640 |
| tamoxifen | affects expression | ISO | RGD:619568 | 6480464 | Tamoxifen affects the expression of CAV1 mRNA | CTD | PMID:14699072 |
| tamoxifen | increases expression | ISO | RGD:619568 | 6480464 | Tamoxifen results in increased expression of CAV1 protein | CTD | PMID:19288272 |
| taurocholic acid | increases secretion | ISO | RGD:619568 | 6480464 | CAV1 protein results in increased secretion of Taurocholic Acid | CTD | PMID:14647059 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:619568 | 6480464 | tert-Butylhydroperoxide results in increased expression of CAV1 mRNA | CTD | PMID:15963989 |
| tetrachloromethane | increases expression | ISO | RGD:1553438 | 6480464 | Carbon Tetrachloride results in increased expression of CAV1 mRNA | CTD | PMID:17484886 |
| theophylline | increases expression | ISO | RGD:619568 | 6480464 | Theophylline results in increased expression of CAV1 mRNA | CTD | PMID:16083514 |
| trans-resveratrol | affects transport | ISO | RGD:619568 | 6480464 | CAV1 protein affects the transport of resveratrol | CTD | PMID:19321006 |
| trans-resveratrol | multiple interactions | ISO | RGD:619568 | 6480464 | resveratrol promotes the reaction [ESR1 protein binds to CAV1 protein binds to SRC protein]; more ... | CTD | PMID:18296501 |
| trans-resveratrol | multiple interactions | ISO | RGD:619568 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CAV1 mRNA | CTD | PMID:19167446 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CAV1 protein | CTD | PMID:18266981 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Streptozocin results in increased expression of CAV1 protein]; more ... | CTD | PMID:18266981 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:619568 | 6480464 | resveratrol results in increased phosphorylation of CAV1 protein | CTD | PMID:18296501 |
| trans-resveratrol | increases response to substance | ISO | RGD:619568 | 6480464 | CAV1 protein results in increased susceptibility to resveratrol | CTD | PMID:19321006 |
| trans-resveratrol | increases expression | ISO | RGD:619568 | 6480464 | resveratrol results in increased expression of CAV1 protein | CTD | PMID:19321006 |
| trimellitic anhydride | decreases expression | ISO | RGD:1553438 | 6480464 | trimellitic anhydride results in decreased expression of CAV1 mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CAV1 mRNA | CTD | PMID:21515302 |
| wortmannin | multiple interactions | ISO | RGD:619568 | 6480464 | wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to Hydrogen Peroxide]; more ... | CTD | PMID:12640124 |